Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence

Journal of Neuroscience

Volumn 21, Issue 23, 2001, Pages 9414-9418

  Volkow, N D ^a   Chang, L ^a   Wang, G J ^a   Fowler, J S ^a   Franceschi, D ^a   Sedler, M ^a   Gatley, S J ^a   Miller, E ^a   Hitzemann, R ^a   Ding, Y S ^a   Logan, J ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Addiction; Detoxification; Dopamine terminal; Dopamine transporters; Imaging; Methamphetamine; Neurotoxicity; Positron emission tomography

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE;

ADAPTIVE BEHAVIOR; ADDICTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MEMORY; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYNAPSE; TASK PERFORMANCE;

EID: 0035576119     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-23-09414.2001     Document Type: Article

References (27)

1. Bradykinin B(2) receptor endocytosis, recycling, and downregulation assessed using green fluorescent protein conjugates
2. Methamphetamine-induced depression of tryptophan hydroxylase: Recovery following acute treatment
3. Quantitation of the human basal ganglia with positron emission tomography: A phantom study of the effect of contrast and axial positioning
4. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine
5. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity
6. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease
7. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss
8. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease
9. Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors
10. Graphical analysis of reversible binding from time activity measurements
11. 11C] raclopride binding in the brain: Model simulations and kinetic analysis of PET data
12. 123I]beta-CIT SPECT
13. 11C]WIN-35,428
14. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey
15. Membrane trafficking regulates the activity of the human dopamine transporter
16. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure
17. Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans
18. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
19. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut
20. Methamphetamine and methylenedioxy-methamphetamine neurotoxicity: Possible mechanisms of cell destruction
21. A new PET ligand for the dopamine transporter: Studies in the human brain
22. Dopamine transporters decrease with age in healthy subjects
23. Dopamine transporter losses in methamphetamine abusers are associated with psychomotor impairment
24. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
25. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
26. Long-term effects of chronic methamphetamine administration in rhesus monkeys
27. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain